GPR54 (KISS1R) transactivates EGFR to promote breast cancer cell invasiveness

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Zajac, Mateusz ^a   Law, Jeffrey ^a   Cvetkovic, Dragana Donna ^a   Pampillo, Macarena ^a   McColl, Lindsay ^a   Pape, Cynthia ^a   Guglielmo, Gianni M ^a   Postovit, Lynne M ^a   Babwah, Andy V ^a   Bhattacharya, Moshmi ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 2; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR 54; GELATINASE B; KISSPEPTIN; KISSPEPTIN 10; G PROTEIN COUPLED RECEPTOR; KISS1 PROTEIN, HUMAN; KISS1R PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL ASSAY; CELL INVASION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE SILENCING; HUMAN; HUMAN CELL; MOLECULAR STABILITY; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; BREAST TUMOR; CELL MOTION; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME ACTIVATION; FEMALE; HUMANS; KISSPEPTINS; MATRIX METALLOPROTEINASE 9; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, G-PROTEIN-COUPLED;

EID: 79959610178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021599     Document Type: Article

References (55)

1. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, et al. (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88: 1731-1737.
2. Hori A, Honda S, Asada M, Ohtaki T, Oda K, et al. (2001) Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Biophys Res Commun 286: 958-963.
3. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, et al. (2001) The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 276: 34631-34636.
4. Makri A, Pissimissis N, Lembessis P, Polychronakos C, Koutsilieris M, (2008) The kisspeptin (KiSS-1)/GPR54 system in cancer biology. Cancer Treat Rev 34: 682-692.
5. Masui T, Doi R, Mori T, Toyoda E, Koizumi M, et al. (2004) Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun 315: 85-92.
6. Shoji S, Tang X, Umemura S, Itoh J, Takekoshi S, et al. (2009) Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor. Eur Urol 55: 441-449.
7. Lee J, Welch D, (1997) Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57: 2384-2387.
8. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, et al. (2001) Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411: 613-617.
9. Yan C, Wang H, Boyd DD, (2001) KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha-induced block of p65/p50 nuclear translocation. J Biol Chem 276: 1164-1172.
10. Marot D, Bieche I, Aumas C, Esselin S, Bouquet C, et al. (2007) High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Endocr Relat Cancer 14: 691-702.
11. Martin TA, Watkins G, Jiang WG, (2005) KiSS-1 expression in human breast cancer. Clin Exp Metastasis 22: 503-511.
12. Campos SM, (2008) Anti-epidermal growth factor receptor strategies for advanced breast cancer. Cancer Invest 26: 757-768.
13. Kim J, Ahn S, Guo R, Daaka Y, (2003) Regulation of epidermal growth factor receptor internalization by G protein-coupled receptors. Biochemistry 42: 2887-2894.
14. Santen RJ, Song RX, McPherson R, Kumar R, Adam L, et al. (2002) The role of mitogen-activated protein (MAP) kinase in breast cancer. J Steroid Biochem Mol Biol 80: 239-256.
15. Gschwind A, Prenzel N, Ullrich A, (2002) Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res 62: 6329-6336.
16. Schafer B, Gschwind A, Ullrich A, (2004) Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23: 991-999.
17. Darmoul D, Gratio V, Devaud H, Peiretti F, Laburthe M, (2004) Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res 2: 514-522.
18. Watt HL, Kharmate GD, Kumar U, (2009) Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells. Cell Signal 21: 428-439.
19. Kim J, Ahn S, Rajagopal K, Lefkowitz RJ, (2009) Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor. J Biol Chem 284: 11953-11962.
20. Ohtsu H, Dempsey PJ, Eguchi S, (2006) ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol 291: C1-10.
21. Franceschini I, Lomet D, Cateau M, Delsol G, Tillet Y, et al. (2006) Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha. Neurosci Lett 401: 225-230.
22. Aziziyeh AI, Li TT, Pape C, Pampillo M, Chidiac P, et al. (2009) Dual regulation of lysophosphatidic acid (LPA1) receptor signalling by Ral and GRK. Cell Signal 21: 1207-1217.
23. Li TT, Alemayehu M, Aziziyeh AI, Pape C, Pampillo M, et al. (2009) Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells. Mol Cancer Res 7: 1064-1077.
24. Shida D, Fang X, Kordula T, Takabe K, Lepine S, et al. (2008) Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Cancer Res 68: 6569-6577.
25. Graham CH, McCrae KR, (1996) Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of preeclamptic patients. Am J Obstet Gynecol 175: 555-562.
26. Elangovan M, Wallrabe H, Chen Y, Day RN, Barroso M, et al. (2003) Characterization of one- and two-photon excitation fluorescence resonance energy transfer microscopy. Methods 29: 58-73.
27. Pampillo M, Camuso N, Taylor JE, Szereszewski JM, Ahow MR, et al. (2009) Regulation of GPR54 signaling by GRK2 and {beta}-arrestin. Mol Endocrinol 23: 2060-2074.
28. Navenot JM, Wang Z, Chopin M, Fujii N, Peiper SC, (2005) Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins. Cancer Res 65: 10450-10456.
29. Roseweir AK, Kauffman AS, Smith JT, Guerriero KA, Morgan K, et al. (2009) Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J Neurosci 29: 3920-3929.
30. Adams LS, Phung S, Yee N, Seeram NP, Li L, et al. Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res 70: 3594-3605.
31. Crisp SJ, Dunn MJ, (1994) Detection of proteins on protein blots using chemiluminescent systems. Methods Mol Biol 32: 233-237.
32. Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, et al. (2006) Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci U S A 103: 1492-1497.
33. Guerrero J, Santibanez JF, Gonzalez A, Martinez J, (2004) EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. Exp Cell Res 292: 201-208.
34. Cortes-Reynosa P, Robledo T, Macias-Silva M, Wu SV, Salazar EP, (2008) Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol 27: 220-231.
35. Hatakeyama M, (2007) System properties of ErbB receptor signaling for the understanding of cancer progression. Mol Biosyst 3: 111-116.
36. Clarke R, Anderson E, Howell A, (2004) Steroid receptors in human breast cancer. Trends Endocrinol Metab 15: 316-323.
37. Price JT, Tiganis T, Agarwal A, Djakiew D, Thompson EW, (1999) Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism. Cancer Res 59: 5475-5478.
38. Zuo Y, Shields SK, Chakraborty C, (2006) Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase. Biochem Biophys Res Commun 351: 361-367.
39. Nicholson KM, Streuli CH, Anderson NG, (2003) Autocrine signalling through erbB receptors promotes constitutive activation of protein kinase B/Akt in breast cancer cell lines. Breast Cancer Res Treat 81: 117-128.
40. Bhattacharya M, Anborgh PH, Babwah AV, Dale LB, Dobransky T, et al. (2002) Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. Nat Cell Biol 4: 547-555.
41. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ, (2001) Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294: 1307-1313.
42. Vousden KH, Lu X, (2002) Live or let die: the cell's response to p53. Nat Rev Cancer 2: 594-604.
43. Rosano L, Cianfrocca R, Masi S, Spinella F, Di Castro V, et al. (2009) Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci U S A 106: 2806-2811.
44. Zou L, Yang R, Chai J, Pei G, (2008) Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis. Faseb J 22: 355-364.
45. Raghuwanshi SK, Nasser MW, Chen X, Strieter RM, Richardson RM, (2008) Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 180: 5699-5706.
46. Chen M, Towers LN, O'Connor KL, (2007) LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells. Am J Physiol Cell Physiol 292: C1927-1933.
47. Caceres M, Guerrero J, Martinez J, (2005) Overexpression of RhoA-GTP induces activation of the Epidermal Growth Factor Receptor, dephosphorylation of focal adhesion kinase and increased motility in breast cancer cells. Exp Cell Res 309: 229-238.
48. Lu Z, Jiang G, Blume-Jensen P, Hunter T, (2001) Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 21: 4016-4031.
49. Wouters FS, Bastiaens PI, (2006) Imaging protein-protein interactions by Fluorescence Resonance Energy Transfer (FRET) microscopy. Curr Protoc Neurosci Chapter 5: Unit 5 22.
50. Parsons M, Messent AJ, Humphries JD, Deakin NO, Humphries MJ, (2008) Quantification of integrin receptor agonism by fluorescence lifetime imaging. J Cell Sci 121: 265-271.
51. Fuentes LQ, Reyes CE, Sarmiento JM, Villanueva CI, Figueroa CD, et al. (2008) Vasopressin up-regulates the expression of growth-related immediate-early genes via two distinct EGF receptor transactivation pathways. Cell Signal 20: 1642-1650.
52. Tilley DG, Kim IM, Patel PA, Violin JD, Rockman HA, (2009) beta-Arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling. J Biol Chem 284: 20375-20386.
53. Maudsley S, Pierce KL, Zamah AM, Miller WE, Ahn S, et al. (2000) The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J Biol Chem 275: 9572-9580.
54. Hart S, Fischer OM, Prenzel N, Zwick-Wallasch E, Schneider M, et al. (2005) GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways. Biol Chem 386: 845-855.
55. Huang J, Hu J, Bian X, Chen K, Gong W, et al. (2007) Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. Cancer Res 67: 5906-5913.